Fierce Biotech Names Accent Therapeutics as One of Its “Fierce 15” Biotech Companies of 2020
LEXINGTON, Mass.–(BUSINESS WIRE)–Accent Therapeutics today announced that it has been named by Fierce Biotech as one of 2020’s Fierce 15
Read morenews
Kane Biotech and Animalcare to Form Animal Health Company to Target Biofilm-Related Ailments
Animalcare to Invest $5 million, Consisting of $3 million to Acquire One-Third Stake in STEM Animal Health, Kane Biotech’s New
Read moreSanofi completes Principia Biopharma Inc. acquisition
Sanofi completes Principia Biopharma Inc. acquisition *Principia Biopharma Inc. is now a wholly owned subsidiary of Sanofi PARIS – September
Read moreAbeona Therapeutics Announces Leadership and Board Transitions
NEW YORK and CLEVELAND, Sept. 28, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene
Read moreTower One to Speak at the RBC Capital Markets Global Tower and Wireless Infrastructure Investor Day
VANCOUVER, British Columbia, Sept. 28, 2020 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower
Read moreImvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) — Imvaq Therapeutics Corp., an innovative cancer immunotherapy company founded by world-leading researchers
Read moreModerna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new
Read moreNovavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
GAITHERSBURG, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines
Read moreSorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
Figure 1: Study PTVA-OA-001: WOMAC (11-point NRS) Question A1 Change from Baseline to Week 12: Pooled Placebo, Pooled RTX, RTX
Read moreCastellum, Inc. Announces Signing of LOI to Acquire Another Government Contractor
Castellum, Inc. – LOI to Acquire Another Government Contractor Castellum, Inc. (OTC: ONOV) announces that it has signed an LOI
Read more